KALA-617

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameKALA-617

Drug Alias Nameinhalable beta-lactam antibiotic (Kala Pharmaceuticals)KALA-617

ClassificationSmall molecules > Heterocyclic drugs > AntibioticsVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCystic FibrosisBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKALA BIO Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKALA BIO Inc

Active IndicationsN/A

Inactive IndicationsCystic FibrosisBacterial Infections

Other Information

ATC CodeN/A